دورية أكاديمية
أعرض في EDS

Plombage for Hemoptysis Control in Pulmonary Aspergilloma: Safety and Effectiveness of Forgettable Surgery in High-Risk Patients.

التفاصيل البيبلوغرافية
العنوان: Plombage for Hemoptysis Control in Pulmonary Aspergilloma: Safety and Effectiveness of Forgettable Surgery in High-Risk Patients.
المؤلفون: Giang NT; Department of Cardiothoracic Surgery, Military Hospital, Vietnam Military Medical University, Ha Noi, Vietnam., Dung LT; Department of Thoracic Surgery, Pham Ngoc Thach Hospital, Ho Chi Minh, Vietnam., Hien NT; Department of Thoracic Surgery, Pham Ngoc Thach Hospital, Ho Chi Minh, Vietnam., Thiet TT; Department of Thoracic Surgery, Pham Ngoc Thach Hospital, Ho Chi Minh, Vietnam., Hiep PS; Department of Thoracic Surgery, Pham Ngoc Thach Hospital, Ho Chi Minh, Vietnam., Pho DC; Department of Infection Control, Military Hospital, Vietnam Military Medical University, Ha Noi, Vietnam., Hung PN; Department of Epidemiology, Vietnam Military Medical University, Ha Noi, Vietnam.; Department of Training, Vietnam Military Medical University, Ha Noi, Vietnam.
المصدر: Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia [Ann Thorac Cardiovasc Surg] 2021 Feb 20; Vol. 27 (1), pp. 10-17. Date of Electronic Publication: 2021 Jan 06.
نوع المنشور: Comparative Study; Journal Article
اللغة: English
بيانات الدورية: Publisher: Japanese Editorial Committee of Annals of Thoracic and Cardiovascular Surgery Country of Publication: Japan NLM ID: 9703158 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2186-1005 (Electronic) Linking ISSN: 13411098 NLM ISO Abbreviation: Ann Thorac Cardiovasc Surg Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Tokyo : Japanese Editorial Committee of Annals of Thoracic and Cardiovascular Surgery,
مواضيع طبية MeSH: Hemostatic Techniques*/adverse effects , Hemostatic Techniques*/instrumentation , Thoracic Surgical Procedures*/adverse effects , Thoracic Surgical Procedures*/instrumentation, Hemoptysis/*surgery , Pulmonary Aspergillosis/*surgery, Adult ; Aged ; Device Removal ; Female ; Hemoptysis/diagnosis ; Hemoptysis/microbiology ; Humans ; Male ; Middle Aged ; Pulmonary Aspergillosis/diagnosis ; Pulmonary Aspergillosis/microbiology ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
مستخلص: Objectives: To evaluate plombage surgery for hemoptysis control in pulmonary aspergilloma in high-risk patients.
Methods: This study was carried out on 75 pulmonary aspergilloma patients presenting with hemoptysis that underwent a plombage surgery for approximately 7 years (November 2011-September 2018) at Pham Ngoc Thach Hospital. They revisited the hospital 6 months after plombage surgery and considered plombage removal. The group whose plombage was removed was compared with that whose plombage was retained 6 and 24 months after surgery.
Results: Hemoptysis reduced significantly after surgery. Hemoptysis ceased in 91.67% of the patients and diminished in 8.33% of the patients 6 months after surgery. Similarly, hemoptysis ceased in 87.32% of the patients and diminished in 12.68% of the patients 24 months after surgery. Body mass index (BMI) index, Karnofsky score, and forced expiratory volume in one second (FEV1) increased. Plombage surgery was performed with operative time of 129.5 ± 36.6 min, blood loss during operation of 250.7 ± 163.1 mL, and the number of table tennis balls of 4.22 ± 2.02. No deaths related to plombage surgery were recorded. Plombage was removed in 29 cases because of patients' requirements (89.8%), infection (6.8%), and pain (3.4%). There were no patient developing complications after the treatment and there were no statistically significant differences between the two groups.
Conclusions: Plombage surgery is safe and effective for hemoptysis control in pulmonary aspergilloma. To minimize the risk of long-term complications, surgeons should remove the plombage 6 months after the initial operation.
References: Turk J Med Sci. 2015;45(2):431-7. (PMID: 26084137)
Exp Ther Med. 2017 May;13(5):2259-2262. (PMID: 28565835)
Eur J Cardiothorac Surg. 2008 Oct;34(4):882-5. (PMID: 18701313)
J Thorac Cardiovasc Surg. 2000 May;119(5):906-12. (PMID: 10788811)
Int J Surg. 2011;9(3):267-71. (PMID: 21252003)
Chest. 2013 May;143(5):1414-1421. (PMID: 23117277)
Korean J Intern Med. 2004 Mar;19(1):38-42. (PMID: 15053042)
Thorax. 1985 May;40(5):328-40. (PMID: 4023987)
Qual Health Care. 1992 Jun;1(2):94-7. (PMID: 10136849)
Ann Thorac Surg. 1997 Jul;64(1):220-4; discussion 224-5. (PMID: 9236365)
Eur J Cardiothorac Surg. 2002 May;21(5):918-23. (PMID: 12062287)
Ann Thorac Surg. 2000 Mar;69(3):898-903. (PMID: 10750780)
BMC Infect Dis. 2015 Nov 26;15:546. (PMID: 26612361)
Thorax. 1997 Sep;52(9):813-5. (PMID: 9371214)
Ann Thorac Surg. 2004 Nov;78(5):1846-8. (PMID: 15511496)
Emerg Radiol. 2019 Oct;26(5):501-506. (PMID: 31129737)
Ann Thorac Surg. 2005 Sep;80(3):1067-72. (PMID: 16122488)
Rev Col Bras Cir. 2014 Nov-Dec;41(6):406-11. (PMID: 25742406)
Int J Mycobacteriol. 2016 Jun;5(2):235-9. (PMID: 27242239)
Ann Thorac Cardiovasc Surg. 2012;18(5):472-4. (PMID: 22446949)
Ann Thorac Cardiovasc Surg. 2015;21(2):125-31. (PMID: 25753208)
Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1609-15. (PMID: 9603145)
Eur J Cardiothorac Surg. 2009 Nov;36(5):910-3. (PMID: 19595606)
Case Rep Surg. 2018 Feb 15;2018:8648732. (PMID: 29666746)
J Hum Kinet. 2017 Jan 30;55:29-38. (PMID: 28210336)
Thorac Surg Clin. 2012 Aug;22(3):345-61. (PMID: 22789598)
J Bronchology Interv Pulmonol. 2017 Jan;24(1):29-34. (PMID: 27623423)
J Med Assoc Thai. 2013 Sep;96 Suppl 4:S142-8. (PMID: 24386754)
فهرسة مساهمة: Keywords: hemoptysis control; plombage surgery; pulmonary aspergilloma
تواريخ الأحداث: Date Created: 20210107 Date Completed: 20210608 Latest Revision: 20210608
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8043030
DOI: 10.5761/atcs.oa.20-00169
PMID: 33408306
قاعدة البيانات: MEDLINE
الوصف
تدمد:2186-1005
DOI:10.5761/atcs.oa.20-00169